InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Mahmood Ladha. Director active across 1 company, notably Swedish Orphan Biovitrum AB (publ). In total, 5 filings have been published. Activity tracked since 24 October 2025. The latest transaction was disclosed on 21 July 2026 (Purchase). Regulator: FIN-FSA. The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations